Prostate diseases in Lagos, Nigeria: A histologic study with tPSA correlation

Prostate diseases in Lagos, Nigeria: A histologic study with tPSA correlation

Objective: To present a 10year retrospective histologic study of prostate diseases in Lagos, Nigeria. The aim is to document the prevalence, histologic pattern, age distribution and PSA values of prostatic diseases. Materials and methods : The materials consisted of slides, paraffin embedded tissu...

Full description

Bibliographic Details
Main Authors:	C C Anunobi, O R Akinde, S O Elesha, A O Daramola, K H Tijani, R W Ojewola
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2011-01-01
Series:	Nigerian Postgraduate Medical Journal
Subjects:	bph prostate cancer prostatitis
Online Access:	http://www.npmj.org/article.asp?issn=1117-1936;year=2011;volume=18;issue=2;spage=98;epage=104;aulast=Anunobi;type=0

Similar Items

Effect of urinary retention on the levels of prostate specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostatic disease
by: R Chawla, et al.
Published: (2003-01-01)

Effect of Finasteride on PSA and Histopathological Results in Patients Undergoing Prostate Biopsy
by: Saman Farshid, et al.
Published: (2022-12-01)

Correlations of Prostate Volume with PSA Levels in BPH Patients at Ulin General Hospital Banjarmasin
by: Nur Ramadhanti Cindy Levissa, et al.
Published: (2021-03-01)

Digital rectal examination (DRE) does not influence total serum levels of prostate specific antigen (tPSA), in individuals without prostate pathology
by: Maria de F. Figueirêdo, et al.
Published: (2003-10-01)

Incidence of histological prostatitis and its correlation with PSA density
by: Affonso Celso Piovesan, et al.
Published: (2009-11-01)

Prostatic disorders in acromegalic patients experience of a Brazilian center
by: Livia L. Correa, et al.
Published: (2013-06-01)

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran
by: L Andonian, et al.
Published: (2005-08-01)

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran
by: L Andonian, et al.
Published: (2005-09-01)

SIGNIFICANCE OF DETECTION OF FREE/TOTAL PSA RATIO AND OTHER BIOCHEMICAL PARAMETERS IN PATIENTS WITH BPH, CARCINOMA PROSTATE AND ITS CLINICOPATHOLOGIC CORRELATION
by: S. Joshi, et al.
Published: (2021-11-01)

Giant Benign Prostatic Hyperplasia in a Pakistani Patient
by: Zafaruddin Khan, et al.
Published: (2014-01-01)

A Review of Prostate Organogenesis and a Role for iPSC-Derived Prostate Organoids to Study Prostate Development and Disease
by: Adriana Buskin, et al.
Published: (2021-12-01)

Prostate – Specific Antigen (Psa) as a Screening Tool for Benign Prostate Hyperplasia (Bph) and Prostate Cancer (Pca) in Sulaimani Province
by: Sirwan M. Muhammad, et al.
Published: (2013-09-01)

Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study
by: Mariantonia Logozzi, et al.
Published: (2019-09-01)

Incidental Prostate Cancer in Patients Treated for Benign Prostatic Hyperplasia: Analysis from a Contemporary National Dataset
by: Eugenio Bologna, et al.
Published: (2024-03-01)

Bladder drainage and glandular epithelial morphometry of the prostate in benign prostatic hyperplasia with severe symptoms
by: Carlos A. Cury, et al.
Published: (2006-04-01)

Applications of Vertebrate Models in Studying Prostatitis and Inflammation-Associated Prostatic Diseases
by: Joosje Bleeker, et al.
Published: (2022-07-01)

Comparative analysis of resected prostate weight in diabetic and non-diabetic benign prostatic hyperplasia patients
by: Emadouddin Moudi, et al.
Published: (2017-02-01)

Incidental Prostate Cancer in Patients Treated for Benign Prostate Hyperplasia in the Period of 21 Years
by: Matea Pirša, et al.
Published: (2018-01-01)

Comparison of the rate of complications after TUEB and cystic prostatectomy in patients with benign prostatic hyperplasia
by: G. V. Bachurin
Published: (2013-08-01)

Bipolar TURP in a patient undergoing redo prostate surgery and the use of PlasmaButton for vaporisation and coagulation
by: A. Pietropaolo, et al.
Published: (2022-06-01)

THE FACTORS ASSOCIATED WITH THE INCIDENCE OF BENIGN PROSTATIC HYPERPLASIA
by: sukron sukron
Published: (2022-07-01)

Prostatic artery embolization: Progress and prospect
by: Li Cui, et al.
Published: (2020-05-01)

Thermobalancing conservative treatment for moderate-to-low-degree lower urinary tract symptoms (LUTS) secondary to prostate enlargement
by: Simon Allen, et al.
Published: (2016-12-01)

THE CORRELATION BETWEEN SERUM PSA LEVEL AND PROSTATE HISTOLOGIC AGGRESSIVENESS WITH PROSTATIC VOLUME IN BPH PATIENTS
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2019-01-01)

Synoptic Versus Narrative Reporting of Prostate Biopsies at a Tertiary Healthcare Institution : Challenges, successes and expectations
by: Nnamdi O. Orah, et al.
Published: (2017-08-01)

The role of the percentage free PSA in the diagnosis of prostate cancer in Blacks: Findings in indigenous West African men using TRUS guided biopsy
by: K.H. Tijani, et al.
Published: (2017-03-01)

Histomorphologic Correlation of PSA Levels in Prostatic Pathology
by: Deepak Panasseril Jayapradeep, et al.
Published: (2017-10-01)

Association Between Prostate Zonal Volume and Erectile Dysfunction in Patients With Benign Prostatic Hyperplasia
by: Muhammed M. Qalawena, MD, et al.
Published: (2020-06-01)

Prostate-specific antigen reduction after empiric antibiotic treatment does not rule out biopsy in patients with lower urinary tract symptoms: prospective, controlled, single-center study
by: Hasan Anıl Atalay, et al.
Published: (2017-06-01)

Bladder stone secondary to prostatic urethral lift (PUL) for benign prostatic hyperplasia (BPH)
by: JiHun Kang
Published: (2021-11-01)

Correlation of Serum Insulin-like Growth Factor 1 with Prostate Cancer
by: Mohsen Ayati, et al.
Published: (2012-10-01)

Treatment Algorithm for Management of Benign Prostatic Obstruction: An Overview of Current Techniques
by: Thomas Hughes, et al.
Published: (2023-10-01)

Emerging Data on the Safety and Efficacy of Transurethral Water Vapour Therapy for Benign Prostatic Hyperplasia
by: Jones P, et al.
Published: (2021-05-01)

Role of Phytotherapy in the Management of BPH: A Summary of the Literature
by: Vaki Antoniou, et al.
Published: (2023-02-01)

Effect of KTP Laser Made byAEOI on Resected Prostateafter Open Prostatectomy
by: MR Razzaghi, et al.
Published: (2008-07-01)

Laparoscopic adenomectomy in BPH – Does it have a role today?
by: Ramalingam Manickam, et al.
Published: (2018-01-01)

MXene-assisted organic electrochemical transistor biosensor with multiple spiral interdigitated electrodes for sensitive quantification of fPSA/tPSA
by: Yi-Cheng Zhu, et al.
Published: (2021-11-01)

Monopolar Transurethral Enucleoresection of Prostate: Feasibility of Modified Nesbit’s Enucleoresection with Apical Release
by: Nitesh Kumar, et al.
Published: (2024-03-01)

Endoscopic enucleation of the prostate with Thulium Fiber Laser (ThuFLEP). A retrospective single-center study
by: Angelis Peteinaris, et al.
Published: (2024-02-01)

Outcomes of prostatic urethral lift in a medically complex population at a veterans affairs hospital
by: Kelly Lehner, et al.
Published: (2022-05-01)